论文信息 - Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. - 字舞流文

Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.

S. Peters | E. Berry-Kravis | T. Benke | D. Glaze | A. Percy | Nancy E. Jones | J. Neul | J. Youakim | James M. Youakim